Search

everythinglearnresearchcommunity

for

Search:↓

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Modulating BMP activity changes the number, size, shape, and type of ectodermal organs.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Mouse hair follicle cells briefly grow during the early hair growth phase, showing that these cells are important for starting the hair cycle.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Finasteride helps increase hair growth in men with hair loss.

African Americans have less hair density than whites.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

Finasteride effectively treats baldness but may cause sexual side effects.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Testosterone's muscle-building effects do not require its conversion to DHT.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Minoxidil can cause skin allergy; use alternative solvents or treatments if allergic.

Male pattern baldness involves hormones and cell signals affecting hair growth.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Higher doses of cranial irradiation are linked to permanent hair loss.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

No treatment fully prevents hair loss from chemotherapy yet.

The document concludes that adult mammalian skin contains multiple stem cell populations with specific markers, important for understanding skin regeneration and related conditions.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.